Abstract

BackgroundMild cognitive impairment is common in chronic HIV infection and there is concern that it may worsen with age. Distinguishing static impairment from on-going decline is clinically important, but the field lacks well-validated cognitive measures sensitive to decline and feasible for routine clinical use. Measures capable of detecting improvement are also needed to assess interventions. The objective of this study is to estimate the extent of change on repeat administration of three different forms of a brief computerized cognitive assessment battery (B-CAM) developed for assessing cognitive ability in the mildly-impaired to normal range in people living with HIV. We hypothesized no change over a six-month period in people on effective antiretroviral therapy.Methods102 HIV+ individuals completed a set of computerized cognitive tasks on three occasions over a six-month period. Rasch analysis was used to determine if change over time (i.e. improvement due to practice) was uniform across tasks and to refine scoring in order to produce three forms of the B-CAM of equivalent level of difficulty. Group-based trajectory analysis (GBTA) was then applied to determine if performance at baseline influenced the magnitude of practice-related improvement on the battery as a whole over the course of follow-up.ResultsTwo cognitive tasks (fluency and word recall) had different levels of difficulty across test sessions, related to the different forms of the tasks. These two items were split by testing session. For all other items, the level of difficulty remained constant across all three time points. GBTA showed that the sample was composed of three distinct groups of people with unique trajectories, defined mainly by level of cognitive ability at baseline. Only the highest group showed an apparent improvement over time, but this change fell within measurement error.ConclusionsRasch analysis provides mathematical confirmation that these three forms of the B-CAM are of equivalent difficulty. GBTA demonstrates that no adjustment of the total score is required to correct for practice effects. Application of these modern statistical methods paves the way towards rapid and robust quantification of change in cognition.

Highlights

  • HIV-Associated Neurocognitive Disorder (HAND) has been reported in as many as 30–60% of people living with HIV [1,2,3,4]

  • Rasch analysis provides mathematical confirmation that these three forms of the Brief Cognitive Ability Measure (B-CAM) are of equivalent difficulty

  • Group-based trajectory analysis (GBTA) demonstrates that no adjustment of the total score is required to correct for practice effects

Read more

Summary

Introduction

HIV-Associated Neurocognitive Disorder (HAND) has been reported in as many as 30–60% of people living with HIV [1,2,3,4]. Existing freely-available cognitive screening tests do not have the sensitivity required to detect the milder cognitive impairment that is the most common presentation in those with well-controlled HIV, and are not suitable to monitor change over time [6,7,8,9,10,11,12]. At this point, clinicians and persons living with HIV are concerned about the potential development of cognitive difficulties and we are addressing this unmet clinical need. We hypothesized no change over a six-month period in people on effective antiretroviral therapy

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call